doi: 10.3389/fmolb.2025.1724944 Received 14 October 2025 Revised 18 November 2025 Accepted 30 November 2025 Published 18 December 2025 Volume 12 - 2025 Edited by Maria Barile, University of Bari Aldo Moro, Italy Reviewed by Anna Maria Giudetti, University of Salento, Italy Maria Tolomeo, National Research Council (CNR), Italy Updates Copyright 2025 Schrder, Jalilvand, Kahl, Kaiser and Liebau
Unlike many supplements that require precise timing windows, TB-500 offers remarkable flexibility in administration schedules
A high-throughput screening of synthetic compounds aimed at identifying substances capable of eliminating tumor cells led to the discovery of erastin, a compound exhibiting RAS-selective activity (65)
10.1111/j.1440-1797.2012.01642.x 31
Metabolic research examines IGF1R signaling effects on glucose uptake, lipid metabolism, and insulin sensitivity